Zhongling Dou

Statistics

Publications

Citations

292

H-Index

Active since

2012

Affiliations

First Affiliated Hospital of Henan University of Science and Technology(Current)

Zhongling Dou is an author at First Affiliated Hospital of Henan University of Science and Technology specializing in medicine, oncology, and molecular oncology.

Publications per year

2012–2021

Publications

miR-24-3p regulates bladder cancer cell proliferation, migration, invasion and autophagy by targeting DEDD

Guoqiang Yu, Zhaohui Jia, Zhongling Dou · Oncology Reports · 2016 · 84 citations · Full text

Life Sciences, Molecular Biology, Oncology +14

Chk1 knockdown confers radiosensitization in prostate cancer stem cells

Xiaobin Wang, Zhikun Ma, Zheng Xiao et al. · Oncology Reports · 2012 · 60 citations · Full text

Medicine, Cancer Biology, Oncology +14

Long noncoding RNA BDNF-AS is associated with clinical outcomes and has functional role in human prostate cancer

Wensheng Li, Zhongling Dou, Shuguang We et al. · Biomedicine & Pharmacotherapy · 2018 · 41 citations

Medicine, Molecular Biology, Molecular Genetics +14

Dual delivery nanoscale device for miR-451 and adriamycin co-delivery to combat multidrug resistant in bladder cancer

Shuguang Wei, Jiannan Gao, Maopeng Zhang et al. · Biomedicine & Pharmacotherapy · 2019 · 30 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17

Activated Wnt/β-Catenin signaling contributes to E3 ubiquitin ligase EDD-conferred docetaxel resistance in prostate cancer

Pan Bian, Zhongling Dou, Zhaohui Jia et al. · Life Sciences · 2019 · 23 citations

Medicine, Molecular Biology, Oncology +12

1–5 of 8